MedTrace Logo

Long-term Characterization of Patients With Severe/Critical Infection by COVID-19 Virus

NCT04559100 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2024-08-28

No results posted yet for this study

Summary

A descriptive study to characterize clinical, radiological, lung function and quality of life alterations in patients who survived a severe or critical disease caused by SARS-COV-2 virus, who were treated in the intensive care unit of a high complexity institution in Cali, Colombia.

Conditions

  • Covid19

Interventions

RADIATION

chest radiography

6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months.

RADIATION

thoracic computed tomography scan

6 and 12 months after hospital discharge, if the patient had a CT scan upon admission to the hospital. If the study is normal at 6 months it will not be repeated at 12 months.

DIAGNOSTIC_TEST

spirometry

6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months.

DIAGNOSTIC_TEST

Diffusing capacity of carbon monoxide

6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months.

DIAGNOSTIC_TEST

6 minute walk test

6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months.

DIAGNOSTIC_TEST

saint george respiratory questionnaire

6 and 12 months after hospital discharge.

Sponsors & Collaborators

  • Fundacion Clinica Valle del Lili

    lead OTHER

Principal Investigators

  • Fernandez · Fundacion Clinica Valle del Lili

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-15
Primary Completion
2021-11-11
Completion
2022-07-01

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04559100 on ClinicalTrials.gov